Search Results

Pharmacotherapy for obesity

Authors: Li, Mingfang; Cheung, Bernard M. Y.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 6, December 2009 , pp. 804-810(7)

Publisher: Blackwell Publishing

Rise in antiobesity drug prescribing for children and adolescents in the UK: a population-based study

Authors: Viner, Russell M.; Hsia, Yingfen; Neubert, Antje; Wong, Ian C. K.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 6, December 2009 , pp. 844-851(8)

Publisher: Blackwell Publishing

Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders

Authors: Heal, David J.; Gosden, Jane; Smith, Sharon L.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 6, December 2009 , pp. 861-874(14)

Publisher: Blackwell Publishing

The cannabinoid R(+)methanandamide induces IL-6 secretion by prostate cancer PC3 cells

Authors: Olea-Herrero, Nuria; Vara, Diana; Malagarie-Cazenave, Sophie; Díaz-Laviada, Inés

Source: Journal of Immunotoxicology, Volume 6, Number 4, December 2009 , pp. 249-256(8)

Publisher: Informa Healthcare

Involvement of adipokines in rimonabant-mediated insulin sensitivity in ob/ob mice

Authors: Mohapatra, Jogeswar; Sharma, Manoranjan; Singh, Satinder; Pandya, Gaurav; Chatterjee, Abhijit; Balaraman, Ramachandran; Patel, Pankaj R.; Jain, Mukul R.

Source: Journal of Pharmacy and Pharmacology, Volume 61, Number 11, November 2009 , pp. 1493-1498(6)

Publisher: Pharmaceutical Press

Effect of the CB₁ receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices

Authors: Mendiguren, Aitziber; Pineda, Joseba

Source: British Journal of Pharmacology, Volume 158, Number 6, November 2009 , pp. 1579-1587(9)

Publisher: Blackwell Publishing

First analysis of pharma uptake after NICE approval

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 587, 2009-09-19 , pp. 5-5(1)

Publisher: Adis International

Rimonabant: First report of partial seizures: case report

Source: Reactions, Volume 1, Number 1271, 2009-09-26 , pp. 28-28(1)

Publisher: Adis International

Pre-exposure to environmental cues predictive of food availability elicits hypothalamic-pituitary-adrenal axis activation and increases operant responding for food in female rats

Authors: Cifani, Carlo; Zanoncelli, Alessandro; Tessari, Michela; Righetti, Claudio; Di Francesco, Carla; Ciccocioppo, Roberto; Massi, Maurizio; Melotto, Sergio

Source: Addiction Biology, Volume 14, Number 4, October 2009 , pp. 397-407(11)

Publisher: Blackwell Publishing

Rimonabant: Atrial fibrillation: 2 case reports

Source: Reactions, Volume 1, Number 1265, 2009-08-15 , pp. 28-29(2)

Publisher: Adis International

The Use of Iontophoresis in the Administration of Nicotine and New Non-Nicotine Drugs through the Skin for Smoking Cessation

Authors: Escobar-Chavez, Jose J.; Merino, Virginia; Lopez-Cervantes, Miriam; Rodriguez-Cruz, Isabel M.a.r.l.e.n.; Quintanar-Guerrero, David; Ganem-Quintanar, Adriana

Source: Current Drug Discovery Technologies, Volume 6, Number 3, September 2009 , pp. 171-185(15)

Publisher: Bentham Science Publishers

Drug Combinations for Dyslipidemia and Obesity Treatment in Metabolic Syndrome

Authors: Florentin, M.; Elisaf, M. S.; Mikhailidis, D. P.; Liberopoulos, E. N.

Source: Current Pharmaceutical Design, Volume 15, Number 29, October 2009 , pp. 3446-3462(17)

Publisher: Bentham Science Publishers

Rimonabant induces partial seizures in a patient with a history of generalized epilepsy

Authors: Braakman, Hilde M.H.; van Oostenbrugge, Robert J.; van Kranen-Mastenbroek, Vivianne H.J.M.; de Krom, Marc C.T.F.M.

Source: Epilepsia, Volume 50, Number 9, September 2009 , pp. 2171-2172(2)

Publisher: Blackwell Publishing

Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis

Authors: Johansson, K.; Neovius, K.; DeSantis, S. M.; Rössner, S.; Neovius, M.

Source: Obesity Reviews, Volume 10, Number 5, September 2009 , pp. 564-575(12)

Publisher: Blackwell Publishing

The Current Status and Future Perspectives of Studies of Cannabinoid Receptor 1 Antagonists as Anti-Obesity Agents

Authors: Lee, Hyeon-Kyu; Choi, Eun B.; Pak, Chwang S.i.e.k.

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 6, April 2009 , pp. 482-503(22)

Publisher: Bentham Science Publishers

Urethane, but not pentobarbitone, attenuates presynaptic receptor function in rats: a contribution to the choice of anaesthetic

Authors: Kurz, CM; Baranowska, U; Łupiński, S; Göthert, M; Malinowska, B; Schlicker, E

Source: British Journal of Pharmacology, Volume 157, Number 8, August 2009 , pp. 1474-1482(9)

Publisher: Blackwell Publishing

Cannabinoid receptor 1 signalling dampens activity and mitochondrial transport in networks of enteric neurones

Authors: boesmans, w.; ameloot, k.; van den abbeel, v.; tack, j.; vanden berghe, p.

Source: Neurogastroenterology and Motility, Volume 21, Number 9, September 2009 , pp. 958-e77(-957)

Publisher: Blackwell Publishing

Tesofensine - a novel potent weight loss medicine

Author: Doggrell, Sheila A

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 7, July 2009 , pp. 1043-1046(4)

Publisher: Informa Healthcare

Effect of antiobesity medications in patients with type 2 diabetes mellitus

Authors: Choussein, Souzana; Makri, Angeliki A.; Frangos, Constantinos C.; Petridou, Eleni Th.; Daskalopoulou, Stella S.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 7, July 2009 , pp. 641-664(24)

Publisher: Blackwell Publishing

Drug Treatment of Obesity: Established and Emerging Therapies

Authors: Isidro, M. L.; Cordido, Fernando

Source: Mini Reviews in Medicinal Chemistry, Volume 9, Number 6, June 2009 , pp. 664-673(10)

Publisher: Bentham Science Publishers